Abbreviation Key: bFGF = basic fibroblast growth factor; HSPG = heparan sulfate proteoglycans; LSN = Low Score Normal; MRF = myogenic regulatory factors; TGF-b = transforming growth factor-b. growth factor-b and regulates collagen fibrillogenesis and cellular growth properties in the avian genetic muscle weakness Low Score Normal. Low Score Normal pectoral muscle development is characterized by a late embryonic increase in the expression of decorin followed by a subsequent increase in collagen crosslinking and modified collagen fibril organization. This paper reviews the interaction of extracellular matrix molecules, cell-extracellular matrix interactions, and modulation of growth factor activity. How proteoglycans may interface with each of these key events during skeletal muscle myogenesis is discussed.
INTRODUCTION
When one considers the formation and structure of tissues, focus is usually directed toward the cellular component. It is often overlooked that cells secrete a network of macromolecules termed the extracellular matrix in which cells are embedded. The extracellular matrix has been classically described as a structural scaffold containing a proteinaceous fiber component (collagen) and an "amorphous ground substance" (proteoglycan) . This definition implies that the extracellular matrix is a static structure with limited ability to influence tissue structure, function, development, or gene expression. It is now known that the extracellular matrix is a dynamic structure that regulates cell behavior through the interaction of extracellular matrix molecules with each other, interaction with growth factors, and through cell-extracellular matrix signal transduction pathways. Furthermore, different tissues have unique extracellular matrices that change as an animal ages.
Collagen biosynthesis is an extremely complex process. There are at least 19 different vertebrate collagens with tissue-specific distributions and unique functional properties. These unique collagen types can be subdivided into the following classes based on function or size: fibrillar; fibril-associated; network forming; filamentous; short chain; and long chain (van der Rest and Garrone, 1991) . Bone contains collagen Type I; cartilage contains collagen Type II, and skeletal muscle contains collagens Type I and III. These collagens are fibrillar in nature. The fibrillar collagens such as Types I through III contain a single triple-helical domain consisting of three separate peptide chains. The three chains wrap around each other, forming an alpha helix, and are linked together by interchain disulfide bonds. After the collagen molecules are synthesized, they are secreted from the cell into the extracellular space and align into a quarter-stagger array; crosslinking between the microfibrils is initiated and larger diameter fibrils form. As an animal ages, collagen crosslinking is progressive, and fiber size increases (Reiser et al., 1992) .
Extracellular matrix proteoglycans are proteins that contain carbohydrates called glycosaminoglycans, which are covalently attached to a central core protein. Figure  1 is a schematic illustrating generalized proteoglycan structure. The glycosaminoglycans are polymers of disaccharide repeats that are highly sulfated, except for hyaluronic acid, and are negatively charged. Typical glycosaminoglycans attached to the proteoglycan central core protein are chondroitin sulfate, dermatan sulfate, heparan sulfate, and keratan sulfate. Proteoglycans interact with cells, collagen, growth factors, and water. Due to the diversity of the extracellular matrix proteoglycan family, proteoglycans may be divided into two major classes: aggregating and nonaggregating interstitial proteoglycans. Aggregating proteoglycans ionically interact with hyaluronic acid, whereas nonaggregating proteoglycans do not associate with hyaluronic acid.
SKELETAL MUSCLE DEVELOPMENT
Myogenesis involves the precise regulation of a number of developmental events, which includes cell adhesion and cell-cell recognition (Miller, 1992; Buckingham, 1994) . These processes are critical in myoblast alignment and fusion into multinucleated myotubes. The formation of multinucleated myotubes is central to skeletal muscle development. The expression of myogenic regulatory factors (MRF) causes cell division to cease and activates the transcription of muscle-specific proteins (Weintraub et al., 1991; Olson, 1992; Edmondson and Olson, 1993; Weintraub, 1993; Lassar et al., 1994) . In addition to the MRF playing a key role in the myogenic process, other macromolecules, such as extracellular matrix components, are also central in regulating muscle differentiation (Fernandez et al., 1991; Florini et al., 1991; McLennan, 1993) . Currently, little information is known about how the muscle extracellular matrix interacts with proliferating and differentiating muscle cells to influence the formation and stabilization of skeletal muscle.
The extracellular matrix has been described as an instructive component in the formation of complex tissue structures (Scott, 1992) . This organizational property of the extracellular matrix involves, in part, the interaction of extracellular matrix molecules with each other, the interaction of cells with the extracellular matrix, and the modulation of growth factor activity. This paper will discuss each of these areas, with focus mainly on the role of the proteoglycan component.
INTERACTION OF EXTRACELLULAR MATRIX MOLECULES
Decorin is a chondroitin/dermatan sulfate proteoglycan that associates with both collagen Types I and II (Vogel et al., 1984; Vogel and Trotter, 1987; Scott, 1988) . Decorin has been identified in a number of tissues, including skeletal muscle (Lennon et al., 1991; Eggen et al., 1994; Velleman et al., 1996; 1997a) . Considerable experimental data suggest that a specific functional interaction occurs between decorin and collagen in the extracellular matrix of soft tissues. Molecular modeling studies have predicted that the decorin core protein binds to collagen in the gap zone between adjacent collagen molecules (Weber et al., 1996) . In vitro experiments support that an interaction between the core protein of decorin and collagen govern the rate and extent of collagen fibrillogenesis (Vogel et al., 1984; Vogel and Trotter, 1987; Scott, 1988) . Furthermore, Danielson et al. (1997) showed in a mouse targeted decorin gene disruption that collagen fibrils were irregular in size and diameter. Although the mice were viable, their skins were extremely fragile and would tear with applied force. These data suggest that decorin influences the maturation of collagen fibrils into larger fibrils and fiber networks. If the organization of collagen is modified then tissue functional properties such as elasticity would be altered.
The chicken Low Score Normal (LSN) genetic muscle disorder is characterized by subnormal muscle development and function. The LSN phenotype was originally detected among F 2 progeny in an outcross between chickens with hereditary muscular dystrophy and a commercial White Leghorn stock (L. J. Pierro and J. S. Haines, University of Connecticut, Storrs, CT, 06268 unpublished data). The LSN nomenclature was selected to distinguish birds that had an impaired ability to right themselves when repeatedly placed on their backs (exhaustion score) but had a higher level of physical strength than muscular dystrophy birds. Exhaustion scores of 0 to 4 characterized the muscular dystrophy birds; scores of 9 to 12 the LSN phenotype; and scores of ≥ 28 characterized normal birds. At 1 wk posthatch, LSN pectoral muscle weights are much lower than those of normal birds [0.74 ± 0.04 (SE) g vs 2.34 ± 0.10 g] (Velleman et al., 1995) .
Prior to 20 d of embryonic development, LSN glycosaminoglycan and proteoglycan levels do not vary significantly from levels expressed in normal muscle (Velleman et al., 1996) ; however, at 20 d of embryonic development there is a dramatic increase in decorin proteoglycan levels. Subsequent to the increase in decorin levels, LSN collagen crosslink levels are elevated nearly 200% by 6 wk posthatch. Although collagen crosslinking is modified, collagen concentration is un- affected. These data are suggestive of an altered distribution of decorin along the collagen fibril that would modify collagen organization as substantiated by increased crosslinking. Changes in decorin expression have not been linked to modulating collagen gene expression.
By transmission electron microscopy, collagen fibril organization was examined at 20 d of embryonic development and 6 wk posthatch (Velleman et al., 1997b) . At embryonic Day 20, both normal and LSN collagen fibril organization was predominantly as single fibrils without any noticeable parallel alignment ( Figure  2) . However, at 6 wk posthatch there was significant parallel alignment of collagen fibrils in the LSN pectoral muscle ( Figure 3B ). This parallel arrangement of collagen fibrils was not observed in normal pectoral muscle at 6 wk posthatch ( Figure 3A ).
CELL-EXTRACELLULAR MATRIX INTERACTIONS
Skeletal muscle cells interact with the extracellular matrix through integrin cell surface molecules (reviewed in Katz and Yamada, 1997) . This cell-matrix association may be involved in myofibril assembly. Integrins are heterodimers composed of an a and b subunit. There are numerous isoforms of each integrin subunit with tissue specific distributions and unique functional properties. In general, integrins are an integral membrane protein that has an extracellular domain that binds to extracellular matrix proteins such as fibronectin, collagen, and laminin, and an intracellular domain that binds to the cellular cytoskeletal network.
Integrins most likely play a critical role during the stages of proliferation, differentiation, and myofibril assembly. It is during these stages that the cell is communicating with the extracellular matrix to regulate cell migration and shape. If the cells are unable to migrate properly, this will alter myoblast alignment and hence fusion into multinucleated myotubes.
Low Score Normal sarcomere organization was modified by 6 wk posthatch. At 20 d of embryonic development, large extracellular spaces were observed with similar sarcomere patterns in both normal and LSN muscle (Figure 4 ). At 6 wk posthatch, normal sarcomeres generally showed a regular pattern with distinct Z banding ( Figure 5A ). In LSN pectoral muscle at 6 wk posthatch, increases in the extracellular space surrounding the sarcomere Z bands were observed ( Figure 5B ), and this phenotype was termed LSN moderate. The 6 wk posthatch LSN pectoral muscle also contained a more severe phenotypic condition characterized by complete sarcomere disorganization, and abnormal mitochondrial shape and enlargement ( Figure 5C ). This extreme LSN phenotype is called LSN severe.
The alteration in LSN sarcomere organization implies more than just a potential extracellular matrix modification of decorin-collagen interactions. If only decorincollagen binding was affected then most likely only collagen fibril organization would be altered, not the sarcomere. Transforming growth factor-b (TGF-b) -1 and -2 have been shown to regulate the level and molecular size of decorin (Bassols and Massagué, 1988) . TGF-b elevates the biosynthetic expression of the 45-kDa decorin core protein and induces an increase in the molecular mass of the glycosaminoglycan chains (Bassols and Massagué, 1988) . During LSN pectoral muscle development, TGF-b2 is upregulated from embryonic Day 20 through 1 wk posthatch (Figure 6 ). This elevation in TGF-b levels corresponds to the increase in decorin synthesis. Low Score Normal decorin glycosaminoglycan chain length has not been assayed to date.
Integrin expression and assembly is regulated by TGF-b expression (Heino et al., 1989; Kagami et al., 1996) . Therefore, if TGF-b is modified, as observed in LSN pectoral muscle, integrin expression and distribution could be altered. Modifications in integrin expression would disrupt normal cell-matrix interactions and cell signal transduction pathways. In vivo, inappropriate communication or signaling between the cell and matrix would lead to changes in cell migration and adhesion, resulting in abnormal sarcomere structure.
Transforming growth factor-b is an inhibitor of both skeletal muscle myoblast proliferation and differentiation. When TGF-b is elevated, one would anticipate a decrease in the proliferation and differentiation that occurs during LSN skeletal muscle development (Li et al., 1997) . Heino and Massagué (1990) have postulated that TGF-b inhibits muscle differentiation by altering both cell adhesion and the expression of myogenin (a muscle regulatory transcription factor). The effect of TGF-b on cell adhesion is through modulation of integrin expression. Alterations in integrin expression will modify cell migration, which is a complex process involving the formation of stable adhesions between the cell and extracellular matrix, cytoskeletal contraction, cell body translocation, and release of cell-extracellular matrix contacts to permit migration. Palecek et al. (1998) have postulated that the degree of cell adhesiveness to a substratum is regulated by integrin expression and distribution. High cell-substratum adhesiveness is due to the formation of integrin aggregate complexes, whereas low cell-substratum adhesiveness is the result of integrin not being in an aggregated state.
Furthermore, decorin also has the potential to alter cell growth properties. Numerous lines of experimental evidence have demonstrated that increased levels of decorin decrease cell proliferation and differentiation (Yamaguchi and Ruoslahti, 1988; Santra et al., 1995) . Moscatello et al. (1998) have reported that decorin activates the epidermal growth factor cellular receptor, which results in the concurrent activation of a mitogenactivated protein kinase signal pathway leading to cell cycle arrest.
MODULATION OF GROWTH FACTOR ACTIVITY
Many proteoglycans function as modulators of growth factor activity. The precise regulation of growth factors is a critical element in muscle proliferation and differentiation. The progression of muscle differentiation from a mononucleated cell to a multinucleated myotube depends on interactions between myoblasts and their environment. Growth factors such as TGF-b and basic fibroblast growth factor (bFGF), which are potent mitogens of muscle differentiation, are, in part, regulated by proteoglycans.
Transforming growth factor-b binds to decorin at its core protein. When TGF-b is bound to the decorin core protein, its activity is suppressed (Yamaguchi et al., 1990) . Interestingly, increases in TGF-b synthesis upregulate decorin (Bassols and Massagué, 1988) , fibronectin (Heino et al., 1989) , collagen (Heino et al., 1989; Heino and Massagué, 1990) , and integrin synthesis (Heino et al., 1989) . TGF-b and decorin may be key players in a feedback regulatory loop. Decorin is a negative regulator of TGF-b and TGF-b in general is a positive regulator of matrix protein synthesis. When decorin is upregulated by TGF-b, decorin core protein synthesis increases and the length of the glycosaminoglycan chains gets longer (Bassols and Massagué, 1988) . The increase in decorin glycosaminoglycan chain length may modify the binding of decorin to collagen, which would alter extracellular matrix architecture through changes in collagen fibril organization. Hence, tissue structure and function would be affected.
The cellular response to bFGF is regulated by the heparan sulfate proteoglycans (HSPG). The HSPG are a diverse group of proteoglycans with at least one heparan sulfate glycosaminoglycan chain attached to the core protein; they are located extracellularly or associated with the plasma or basement membrane (Timpl, 1993) . The membrane-associated HSPG interact with the cellular cytoskeleton (Bernfield et al., 1992; Carey et al., 1994) . These proteoglycans, therefore, may be critical players in regulating cell-matrix signal transduction by modulating the response of a cell to changes in its environment. The membrane-associated HSPG are either present in the plasma membrane by a transmembrane core protein domain (Marynen et al., 1989; Saunders et al., 1989) or by a glycosylphosphatidylinositol anchor (Cole and Burg, 1989; Carey and Stahl, 1990) .
The presence of proteoglycans has been shown to be necessary for skeletal muscle differentiation . Basic fibroblast growth factor is a stimulator of skeletal muscle proliferation and a potent inhibitor of skeletal muscle differentiation. The binding of bFGF to its skeletal muscle receptor is dependent on heparan sulfate proteoglycan (Aviezer et al., 1994) . If heparan sulfate is removed, bFGF no longer inhibits muscle differentiation (Rapraeger et al., 1991) .
The regulation of the various HSPG is not random. For example, the transmembrane heparan sulfate proteoglycan, syndecan, is down-regulated with skeletal muscle differentiation (Larrain et al., 1997) , whereas the FIGURE 6. Transforming growth factor-b2 (TGF-b2) steady-state transcript levels in control and Low Score Normal (LSN) pectoral muscle at embryonic Day 14, 19, 20, and 1 d and 1 wk posthatch (PH). Slot blots were hybridized to a TGF-b2 cDNA and hybridization intensity is graphically reported as the average optical density (OD) ± SE after 18S RNA normalization. An asterisk indicates a difference (P < 0.05) between control and LSN groups.
glycosyphosphatidylinositol anchor proteoglycan, glypican, is up-regulated . The significance of this differential regulation of these HSPG is currently unknown. Elucidating the biological mechanism regulating heparan sulfate proteoglycan expression will further our understanding of skeletal muscle development and bFGF regulation.
CONCLUSIONS
Skeletal muscle proteoglycans are precisely regulated in a dynamic fashion during skeletal muscle development. Regulation of both proteoglycan synthesis and spatial distribution may play a key role in tissue morphogenesis in terms of the response to growth factors, cellular growth, and extracellular matrix architecture. Proteoglycans such as decorin are critical in modulating TGF-b, cellular growth properties, and collagen fibril organization. The heparan sulfate family of proteoglycans are crucial in regulating the cellular response to bFGF. However, the developmental pattern of proteoglycan expression and the precise biological function of each type of proteoglycan still remains an enigma. Continued analysis of proteoglycan expression during myogenesis will help us understand the role of the proteoglycans in skeletal muscle myogenesis.
